利奈唑胺与万古霉素治疗耐甲氧西林金黄色葡萄球菌医院获得性肺炎：亚组分析的微妙之处 - Suppr

Suppr

超能文献

Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.

作者信息

Powers John H, Ross David B, Lin Daphne, Soreth Janice

出版信息

Chest. 2004 Jul;126(1):314-5; author reply 315-6. doi: 10.1378/chest.126.1.314.

DOI:10.1378/chest.126.1.314

PMID:15249482

Abstract

摘要

相似文献

Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.利奈唑胺与万古霉素治疗耐甲氧西林金黄色葡萄球菌医院获得性肺炎：亚组分析的微妙之处

Chest. 2004 Jul;126(1):314-5; author reply 315-6. doi: 10.1378/chest.126.1.314.

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.利奈唑胺与万古霉素对比：耐甲氧西林金黄色葡萄球菌医院获得性肺炎患者两项双盲研究的分析

Chest. 2003 Nov;124(5):1789-97.

Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.利奈唑胺与万古霉素治疗耐甲氧西林金黄色葡萄球菌引起的医院获得性肺炎的成本效益分析。

Clin Ther. 2007 Apr;29(4):759-60; author reply 760-1.

Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.万古霉素与利奈唑胺治疗耐甲氧西林金黄色葡萄球菌医院获得性肺炎：ZEPHyR 试验的意义。

Ann Pharmacother. 2012 Oct;46(10):1432-5. doi: 10.1345/aph.1R221. Epub 2012 Sep 4.

Clin Ther. 2007 Feb;29(2):381-3; author reply 383-4. doi: 10.1016/j.clinthera.2007.02.010.

Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.胸外科手术后耐甲氧西林金黄色葡萄球菌肺炎：万古霉素治疗失败后利奈唑胺成功治愈

Ann Thorac Surg. 2007 May;83(5):1888-91. doi: 10.1016/j.athoracsur.2006.11.068.

Nosocomial pneumonia: therapy is just not good enough.医院获得性肺炎：治疗效果仍不尽人意。

Chest. 2003 Nov;124(5):1632-4. doi: 10.1378/chest.124.5.1632.

Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.利奈唑胺治疗耐甲氧西林金黄色葡萄球菌医院获得性肺炎的随机对照研究。

Clin Infect Dis. 2012 Mar 1;54(5):621-9. doi: 10.1093/cid/cir895. Epub 2012 Jan 12.

Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌所致医院获得性肺炎的药物治疗选择

Ann Pharmacother. 2007 Feb;41(2):235-44. doi: 10.1345/aph.1H414. Epub 2007 Feb 13.

Linezolid in VAP by MRSA: a better choice?利奈唑胺用于耐甲氧西林金黄色葡萄球菌所致呼吸机相关性肺炎：是更好的选择吗？

Intensive Care Med. 2004 Mar;30(3):343-6. doi: 10.1007/s00134-003-2135-y. Epub 2004 Feb 6.

引用本文的文献

Innovation in the Design of Clinical Trials for Infectious Diseases: Focusing on Patients Over Pathogens.传染病临床试验设计的创新：以患者而非病原体为重点。

Pharmaceut Med. 2025 Mar;39(2):73-86. doi: 10.1007/s40290-025-00552-3. Epub 2025 Mar 12.

Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.利奈唑胺与万古霉素治疗疑似耐甲氧西林金黄色葡萄球菌医院获得性肺炎的疗效比较：一项采用荟萃分析的系统评价

Eur J Clin Pharmacol. 2015 Jan;71(1):107-15. doi: 10.1007/s00228-014-1775-x. Epub 2014 Oct 30.

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis.利奈唑胺与万古霉素治疗医院获得性肺炎的系统评价与荟萃分析。

BMJ Open. 2013 Oct 14;3(10):e003912. doi: 10.1136/bmjopen-2013-003912.

Aspiration pneumonia after stroke: intervention and prevention.中风后吸入性肺炎：干预与预防

Neurohospitalist. 2011 Apr;1(2):85-93. doi: 10.1177/1941875210395775.

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.利奈唑胺与万古霉素或替考拉宁治疗医院获得性肺炎的比较：随机对照试验的荟萃分析。

Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1121-8. doi: 10.1007/s10096-013-1867-z. Epub 2013 Apr 10.

Managing Severe Community-Acquired Pneumonia Due to Community Methicillin-Resistant Staphylococcus aureus (MRSA).管理耐甲氧西林金黄色葡萄球菌（MRSA）引起的严重社区获得性肺炎。

Curr Infect Dis Rep. 2012 Jun;14(3):330-8. doi: 10.1007/s11908-012-0254-8.

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.医院获得性耐甲氧西林金黄色葡萄球菌（MRSA）肺炎：利奈唑胺还是万古霉素？- 比较药理学和临床疗效。

Eur J Med Res. 2010 Nov 30;15(12):507-13. doi: 10.1186/2047-783x-15-12-507.

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.替拉万星与万古霉素治疗革兰阳性菌所致医院获得性肺炎。

Clin Infect Dis. 2011 Jan 1;52(1):31-40. doi: 10.1093/cid/ciq031.

Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.利奈唑胺与糖肽类抗生素治疗疑似耐甲氧西林金黄色葡萄球菌医院获得性肺炎的比较：一项随机对照试验的荟萃分析。

Chest. 2011 May;139(5):1148-1155. doi: 10.1378/chest.10-1556. Epub 2010 Sep 23.

Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus.利奈唑胺与万古霉素治疗耐甲氧西林金黄色葡萄球菌感染患者的全国队列比较效果研究。

Antimicrob Agents Chemother. 2010 Oct;54(10):4394-400. doi: 10.1128/AAC.00200-10. Epub 2010 Jul 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验